AFP
EW icon

Ausdal Financial Partners’s Edwards Lifesciences EW Stock Holding History

Ausdal Financial Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,049
Closed -$54K – 455
2015
Q4 		$54K Buy
+2,049
New +$53.2K 0.03% 433

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ausdal Financial Partners's EW Position: Q1 2016 in Review

Ausdal Financial Partners sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 2,049 shares — an estimated $54K sold.

Ausdal Financial Partners first reported a position in EW in Q4 2015 and held it in 1 quarter. The position peaked at $54K in Q4 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

  • Ausdal Financial Partners reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
  • Ausdal Financial Partners sold 2,049 Edwards Lifesciences shares in Q1 2016, an estimated $54K.
  • Ausdal Financial Partners first reported a position in Edwards Lifesciences in Q4 2015 and held it in 1 quarter.
  • Ausdal Financial Partners's Edwards Lifesciences position peaked at $54K in Q4 2015.
  • 659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Ausdal Financial Partners's 13F filing for Q1 2016, filed 5 May 2016.